Chinese COVID Drug VV116 Shows Promise Against Deadly Nipah Virus
News
F
Firstpost•28-01-2026, 19:01
Chinese COVID Drug VV116 Shows Promise Against Deadly Nipah Virus
- •A new study reveals that VV116, an oral antiviral drug originally for COVID-19, could effectively treat Nipah virus infections.
- •Researchers from Wuhan Institute of Virology found VV116 prevented Nipah virus strains in labs and improved survival rates in animal trials.
- •The drug significantly reduced viral load in key organs like lungs, spleen, and brain in golden hamsters, increasing their survival to 66.7%.
- •VV116 showed strong antiviral activity against both Malaysia and Bangladesh strains of Nipah, with Bangladeshi strains linked to Indian outbreaks.
- •With no current vaccine or cure for Nipah, VV116 offers potential as a preventive treatment for high-risk groups and a readily available option for outbreaks.
Why It Matters: An existing Chinese COVID-19 drug, VV116, shows significant promise as a treatment for the deadly Nipah virus.
✦
More like this
Loading more articles...
